Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumor-targeted cell killing with 8-hydroxyquinolyl-glucuronide.

K J Henle1, T P Monson, W A Nagle

  • 1Department of Medicine, University of Arkansas for Medical Sciences, Little Rock.

Radiation Research
|August 1, 1988
PubMed
Summary

Elevated beta-glucuronidase in RIF-1 tumors suggests a novel cancer therapy. Targeting this enzyme with 8-hydroxyquinoline (8-OHQ) glucuronides may enhance drug delivery and efficacy for improved tumor treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The ballistocardiographic response to hyperthermia. (Res Rep MR005. 13-7004, Rep).

Research report. Naval School of Aviation Medicine (U.S.)·2014
Same author

The long-QT syndrome Genetic considerations.

Trends in cardiovascular medicine·2011
Same author

Cystic fibrosis of the pancreas.

Minnesota medicine·2010
Same author

Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases.

European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·2007
Same author

Mutation-specific pharmacology of the long QT syndrome.

Handbook of experimental pharmacology·2006
Same author

Effects of lipids and lipid-lowering therapy on hemostatic factors in patients with myocardial infarction.

Journal of thrombosis and haemostasis : JTH·2004

Area of Science:

  • Biochemistry
  • Oncology
  • Pharmacology

Background:

  • Tumors often exhibit elevated hydrolytic enzyme levels, potentially linked to invasive processes.
  • The RIF-1 murine tumor model displays significantly higher beta-glucuronidase activity compared to liver tissue.
  • Elevated tumor beta-glucuronidase presents a therapeutic target for enzyme-activated prodrug strategies.

Purpose of the Study:

  • To investigate the potential of targeting elevated beta-glucuronidase in RIF-1 tumors using 8-hydroxyquinoline (8-OHQ) as a model compound.
  • To evaluate the efficacy of systemically administered 8-hydroxyquinolyl-glucuronide for tumor-specific drug release and cytotoxicity.
  • To explore combination therapies involving 8-OHQ, hyperthermia, and X-radiation for enhanced anti-tumor effects.

Main Methods:

Related Experiment Videos

  • Assessed beta-glucuronidase activity in RIF-1 tumors and liver tissue of C3H mice.
  • Quantified phenolphthalein release from its glucuronide in RIF tumors versus liver.
  • Performed in vitro cytotoxicity assays using 8-OHQ and 8-hydroxyquinolyl-glucuronide on RIF tumor cells.
  • Investigated the effects of combining 8-OHQ with hyperthermia or X-radiation on RIF tumor cell survival.

Main Results:

  • RIF-1 tumors exhibited substantially higher beta-glucuronidase activity than liver tissue, releasing significantly more phenolphthalein from its glucuronide.
  • Low concentrations of 8-OHQ (1-10 microM) demonstrated potent in vitro cytotoxicity against RIF tumor cells.
  • 8-hydroxyquinolyl-glucuronide showed only modest cytotoxicity, indicating limited prodrug activation at the tested concentration.
  • Combination treatments of 8-OHQ with hyperthermia or X-radiation did not significantly alter RIF tumor cell survival curves in vitro.

Conclusions:

  • Elevated beta-glucuronidase in RIF-1 tumors provides a basis for targeted prodrug therapy.
  • While 8-hydroxyquinolyl-glucuronide showed limited direct cytotoxicity, the concept of targeted 8-OHQ delivery is promising.
  • Further in vivo studies are warranted to explore the therapeutic potential of combining targeted 8-OHQ delivery with local hyperthermia and/or irradiation for enhanced cancer treatment.